Protective Effect of Carnosine on Subcortical Ischemic Vascular Dementia in Mice
- 3 September 2012
- journal article
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 18 (9) , 745-753
Abstract
Summary: Aims: Recently, we found carnosine protects against N‐Methyl‐D‐Aspartate (NMDA) induced excitotoxicity through a histaminergic pathway. The aim of this study was to determine whether the carnosine‐histidine‐histamine pathway also played a protective role in subcortical ischemic vascular dementia (SIVD).Methods: Adult male mice (C57BL/6 strain) were subjected to right unilateral common carotid arteries occlusion (rUCCAO) and treated with carnosine or histidine. Object recognition test, passive avoidance task, Morris water maze, and immunohistochemical analyses were performed after rUCCAO.Results: We found that carnosine (200, 500 mg/kg) ameliorated white matter lesion and cognitive impairment evaluated by object recognition test, passive avoidance task, and Morris water maze test after rUCCAO in both wide‐type mice and histidine decarboxylase knockout mice, which are lack of endogenous histamine. However, administration of histidine did not show the same effect. The myelin basic protein in the corpus callosum decreased obviously at day 37 after rUCCAO, which was largely reversed by carnosine (200, 500 mg/kg). Carnosine (200, 500 mg/kg) suppressed the activation of microglia and astrocyte as attenuating the elevation of glial fibrillary acidic protein (GFAP) and Iba‐1 fluorescent intensity. Moreover, carnosine (200, 500 mg/kg) significantly attenuated the increase in reactive oxygen species generation after rUCCAO.Conclusion: These data suggest that the neuroprotective effect of carnosine on rUCCAO in mice is not dependent on the histaminergic pathway, but may be due to a suppression of reactive oxygen species generation, glia activation, and myelin degeneration.Keywords
This publication has 45 references indexed in Scilit:
- N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s DiseaseCurrent Alzheimer Research, 2012
- Subcortical vascular dementiaNeuroscience Research, 2011
- Attenuation of Brain Damage and Cognitive Impairment by Direct Renin Inhibition in Mice With Chronic Cerebral HypoperfusionHypertension, 2011
- Cell-based therapy for patients with vascular dementiaPsychogeriatrics, 2011
- Citicoline in Vascular Cognitive Impairment and Vascular Dementia After StrokeStroke, 2011
- Histamine Pharmacology and New CNS Drug TargetsCNS Neuroscience & Therapeutics, 2010
- Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factorsThe Lancet Neurology, 2008
- Histamine in the Nervous SystemPhysiological Reviews, 2008
- Vascular risk factors, cognitve decline, and dementiaVascular Health and Risk Management, 2008
- Treatment of vascular dementia: evidence from trials with non-cholinergic drugsJournal of the Neurological Sciences, 2004